About 200 reports

  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H2 2017
  • PTX-15 - DRUG PROFILE

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • Transplantation
  • Astellas Pharma Inc.
  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H1 2018
  • HEART TRANSPLANT REJECTION - PIPELINE BY NOXXON PHARMA AG, H1 2018

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • Target
  • Target

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • Targeted Therapy
  • Novartis AG

HEART TRANSPLANT SURGERY ##. ##. ##.

  • Cardiology
  • Health Services
  • World
  • Forecast
  • Market Size

Food and Drug Administration (FDA), World Health Organization (WHO), GLOBOCAN, and various organ transplant registries.

  • Cardiology
  • Medical Device
  • North America
  • United States
  • Zimmer Biomet Holdings, Inc.
  • DORMANT PRODUCTS, H2 2018 (CONTD..1), H2 2018

## ## ## Universities/ Institutes ## ## ## ## ## ## PRODUCTS UNDER DEVELOPMENT BY INDICATION NUMBER OF PRODUCTS UNDER DEVELOPMENT BY TOP ## INDICATIONS, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H## 2018 Indication Source: Global Markets Dire

  • Cancer
  • Cardiology
  • Immunotherapy
  • Targeted Therapy
  • Apexigen, Inc.

Especially important for heart failure patients is the ability to return home, with their loved ones, as they await heart transplantation.

  • Cardiology
  • Clinical Trial
  • Pump
  • United States
  • Impella CardioSystems AG
  • IMPELLA RP - PRODUCT DESCRIPTION

Especially important for heart failure patients is the ability to return home, with their loved ones, as they await heart transplantation.

  • Cardiology
  • Clinical Trial
  • Prosthesis
  • United States
  • Impella CardioSystems AG
  • GLOBAL NUMBER OF PROCEDURES DATA, 2017/2018
  • Cardiac Rehabilitation Practices in Latin America

ANNOUNCED IT HAS RECEIVED FDA APPROVAL FOR ITS HEARTWARE HVAD SYSTEM AS A DESTINATION THERAPY FOR PATIENTS WITH ADVANCED HEART FAILURE WHO ARE NOT CANDIDATES FOR HEART TRANSPLANTS.

  • Cardiology
  • Forecast
  • Market Size
  • Abbott
  • Boston Scientific Corporation
  • Target

The prominent features of this report are - ##.

  • Cardiology
  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative

HEART TRANSPLANT SURGERY ##. ##. ##.

  • Cardiology
  • Health Services
  • Hospital
  • North America
  • Market Size

HEART TRANSPLANT SURGERY ##. ##. ##.

  • Cardiology
  • Health Services
  • Europe
  • Market Size

The prominent features of this report are - ##.

  • Cardiology
  • Monoclonal Antibody
  • Pharmaceutical
  • Targeted Therapy
  • World

HEART TRANSPLANT SURGERY ##. ##. ##.

  • Cardiology
  • Health Services
  • APAC
  • Market Size
  • IMPELLA RP - PRODUCT DESCRIPTION
  • FEB 13, 2018: ABIOMED RECEIVES APPROVAL FOR EXPANDED FDA INDICATION FOR CARDIOMYOPATHY WITH CARDIOGENIC SHOCK

Abiomed' s right-side heart pump, the Impella RP®device, is FDA approved to treat patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart su

  • Cardiology
  • Heart Failure
  • United States
  • Product Initiative
  • Abiomed, Inc.

Almost all of these artificial hearts are used as a bridge to human heart transplantation.

  • Cardiology
  • World
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • US: FLUOROSCOPY EQUIPMENT MARKET FOR SURGICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)

Moreover, around ## heart transplants are performed in Canada each year.

  • Cardiology
  • North America
  • United States
  • GE Healthcare Limited
  • Shimadzu Corporation

Global Number Of Heart Transplant Procedures Performed, 2016, By Country; ##. ##.

  • Cardiology
  • Cardiovascular Devices
  • Health Services
  • World
  • Market Size

It offers vascular access devices through its Cardiac and Vascular division.

  • Cardiology
  • Hospital
  • Forecast
  • Market Size
  • Teleflex Incorporated
  • 7.1 INTRODUCTION

cardiac transplantation. ##. ##. ##. ## ##. ##. ## CARDIOLOGY TABLE ## HEALTHCARE EDUCATION SERVICES MARKET FOR CARDIOLOGY, BY REGION, 2016-2023 (USD MILLION) TABLE ## In 2018, North America accounted for the largest share of the healthcare education services mar

  • Cardiology
  • Education And Training
  • North America
  • United States
  • GE Healthcare Limited

The company is the first to introduce Full Maglev In 2018, HeartMate ## LVAD was approved for long term use in patients for unviable candidates of heart transplant.

  • Cardiology
  • World
  • Market Size
  • B. Braun Medical
  • Boston Scientific Corporation

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Clinical Trial
  • Lung Transplant
  • Monoclonal Antibody
  • Targeted Therapy
  • Novartis AG

According to a 2017 article by the American College of Cardiology, SAVR is widely regarded as one of the most life-saving cardiac procedures ever developed.

  • Cardiology
  • North America
  • United States
  • Boston Scientific Corporation
  • Medtronic, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Targeted Therapy
  • World
  • Product Initiative
  • Conatus Pharmaceuticals Inc.

More than ##% of US heart transplant centers are now using the guideline-recommended AlloMap for heart transplant patient surveillance.

  • Cardiology
  • United States
  • Company Financials
  • Market Size
  • MiMedx Group, Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cardiology
  • Clinical Trial
  • Drug Development
  • Targeted Therapy
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cardiology
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery
  • Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations

Abiomed' s right-side heart pump, the Impella RP®device, is FDA approved to treat patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart su

  • Cardiology
  • Pump
  • United States
  • Market Size
  • Abiomed, Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2019 (CONTD..4), H1 2019
  • DORMANT PRODUCTS, H1 2019 (CONTD..1), H1 2019

MP## is currently in phase ##.

  • Cancer
  • Cardiology
  • Targeted Therapy
  • World
  • Apexigen, Inc.